Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians
Status:
Withdrawn
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study is designed to validate the Japanese electronic florbetapir (18F) interpretation
training program intended for post-approval implementation in Japan.